These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. CLINICAL TRIALS IN PROGRESS: LEUKAEMIA AND MULTIPLE MYELOMA. GALTON DA Proc R Soc Med; 1965 Aug; 58(8):630-2. PubMed ID: 14341851 [No Abstract] [Full Text] [Related]
8. SEVERAL CELL-LINES WITH ABNORMAL KARYOTYPES IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKAEMIA. PEDERSEN B; VIDEBAEK A Scand J Haematol; 1964; 1():129-37. PubMed ID: 14184546 [No Abstract] [Full Text] [Related]
9. EFFECT OF ANTI-LEUKAEMIC AGENTS ON CERTAIN PARASITIC INFESTATIONS IN MAN. GHOSE S; CHOWDHURY AB; RAY RN; CHATTERJEA JB Bull Calcutta Sch Trop Med; 1964 Jan; 12():10-2. PubMed ID: 14154254 [No Abstract] [Full Text] [Related]
10. Effect of my-leran and 6-mercaptopurine (6-MP) on the serum level of vitamin B12 in chronic myelocytic leukemia. DOCTOR VM; BERGSAGEL DE; SHULLENBERGER CC Blood; 1959 Mar; 14(3):274-8. PubMed ID: 13628825 [No Abstract] [Full Text] [Related]
11. [Prolonged remission in subacute myeloid leukemia achieved by consecutive administration of 6-mercaptopurine and myleran]. SHAPIRO ZA; TIMOSHKINA LF Pediatriia; 1958 Aug; 22(8):65-7. PubMed ID: 13590888 [No Abstract] [Full Text] [Related]
12. Evaluation of the comparative effectiveness of Myleran and 6-MP in the management of patients with chronic myelocytic leukemia. SHULLENBERGER CC Cancer Chemother Rep; 1962 Feb; 16():203-7. PubMed ID: 13912386 [No Abstract] [Full Text] [Related]
14. EFFECT OF ADMINISTRATION OF ALKYLATING AGENTS OR 6-MERCAPTOPURINE ON SERUM LEVEL OF DEOXYRIBONUCLEASE I IN LEUKEMIA PATIENTS. DOCTOR VM; DE BERGSAGEL DE; SHULLENBERGER CC Proc Soc Exp Biol Med; 1963 Oct; 114():244-6. PubMed ID: 14076898 [No Abstract] [Full Text] [Related]
16. DRUGS IN THE TREATMENT OF LEUKAEMIA. ROSS ED; SETTLE JA; TELFER AB Br Med J; 1963 Nov; 2(5365):1111-2. PubMed ID: 14057717 [No Abstract] [Full Text] [Related]
17. CHRONIC MYELOID LEUKEMIA WITH PRIAPISM IN EIGHT-YEAR-OLD CHILD. RITZ ND; PURFAR M N Y State J Med; 1964 Feb; 64():553-6. PubMed ID: 14125418 [No Abstract] [Full Text] [Related]
18. DEFICIENCY OF THE HYDRAZINE SENSITIVE COMPONENT OF COMPLEMENT IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA. INAI S; FUJIKAWA K; MASAOKA T; TAKAHASHI H; NAGAKI K Biken J; 1963 Jul; 6():37-43. PubMed ID: 14147704 [No Abstract] [Full Text] [Related]
19. THE LOCAL INFLAMMATORY RESPONSE IN PATIENTS WITH BLOOD DYSCRASIAS AS TESTED BY THE SKIN WINDOW TECHNIQUE. WEBER RE; HELMAN N Bull Sinai Hosp Detroit; 1963; 11():95-9. PubMed ID: 14064458 [No Abstract] [Full Text] [Related]
20. [Treatment of leukemia in childhood]. HUTH E Med Welt; 1963 May; 20():1124-6. PubMed ID: 13955941 [No Abstract] [Full Text] [Related] [Next] [New Search]